RCT-RITS, A LARGE, RANDOMISED PLACEBO-CONTROLLED ADD-ON TRIAL OF RITUXIMAB IN PSYCHOSIS: PRELIMINARY FINDINGS (WPA-WCP 2026) - Oct 15, 2026 - Pres time: Sep 24, 2026; 02:00 PM - 02:10 PM; Location: Hall K16; "An effective treatment for psychosis would have substantial benefits for patients and society by reducing the need for inpatient and compulsory care, improving long-term functional outcomes, and enabling social participation."
Clinical • CNS Disorders • Mood Disorders • Obsessive-Compulsive Disorder • Psychiatry • Schizophrenia
|